Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Liver Diseases

  Free Subscription

Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 53 articles:
HTML format

Single Articles

    April 2019
  1. SCHIELKE A, Scatton O, Boelle PY, Perdigao F, et al
    Ischemic-type biliary lesions: A leading indication of liver retransplantation with excellent results.
    Clin Res Hepatol Gastroenterol. 2019;43:131-139.
    PubMed     Abstract available

  2. MURATORI P, Lenzi M, Muratori L
    Diagnosis of primary biliary cholangitis in a "teen" male patient.
    Clin Res Hepatol Gastroenterol. 2019;43:e20-e21.

    February 2019
  3. POUJOIS A, Woimant F
    Answer to challenging issues in the management of Wilson's disease.
    Clin Res Hepatol Gastroenterol. 2019;43:e7-e8.

  4. GUILLAUD O, Dumortier J, Traclet J, Restier L, et al
    Assessment of liver fibrosis by transient elastography (Fibroscan((R))) in patients with A1AT deficiency.
    Clin Res Hepatol Gastroenterol. 2019;43:77-81.
    PubMed     Abstract available

  5. YU C, Wang L, Xue H, Lin H, et al
    Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.
    Clin Res Hepatol Gastroenterol. 2019;43:58-66.
    PubMed     Abstract available

  6. BAKER A, Kerkar N, Todorova L, Kamath BM, et al
    Systematic review of progressive familial intrahepatic cholestasis.
    Clin Res Hepatol Gastroenterol. 2019;43:20-36.
    PubMed     Abstract available

  7. LEONI MC, Amelung L, Lieveld FI, van den Brink J, et al
    Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease.
    Clin Res Hepatol Gastroenterol. 2019;43:37-44.
    PubMed     Abstract available

  8. BIOULAC-SAGE P, Sempoux C, Frulio N, Le Bail B, et al
    Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes.
    Clin Res Hepatol Gastroenterol. 2019;43:12-19.
    PubMed     Abstract available

  9. CASTRO NARRO GE, Consuelo Sanchez A, Salazar Martinez A, Gamboa Dominguez A, et al
    The silent course of liver steatosis and fibrosis in an adult patient with Cholesteryl Ester Storage Disease.
    Clin Res Hepatol Gastroenterol. 2019;43:e4-e6.

  10. LOESCH R, Desbois-Mouthon C, Colnot S
    Potentials of CRISPR in liver research and therapy.
    Clin Res Hepatol Gastroenterol. 2019;43:5-11.
    PubMed     Abstract available

    January 2019
  11. LEBRAY P, Varnous S
    Combined heart and liver transplantation: State of knowledge and outlooks.
    Clin Res Hepatol Gastroenterol. 2019 Jan 8. pii: S2210-7401(18)30173.
    PubMed     Abstract available

    December 2018
    Challenging issues in the management of Wilson's disease.
    Clin Res Hepatol Gastroenterol. 2018;42:e95-e96.
    PubMed     Abstract available

    October 2018
  13. RAMADAN HK, Makhlouf NA, Mahmoud AA, Abd Elrhman M, et al
    Role of vitamin D deficiency as a risk factor for infections in cirrhotic patients.
    Clin Res Hepatol Gastroenterol. 2018 Oct 11. pii: S2210-7401(18)30182.
    PubMed     Abstract available

  14. LE BAIL B, Chiche L, Balabaud C, Bioulac-Sage P, et al
    Collision of hepatocellular nodules in vascular livers: A medical challenge.
    Clin Res Hepatol Gastroenterol. 2018;42:e83-e85.

    August 2018
  15. WANG C, Huang Z, Huang X, Liu C, et al
    Surgical outcomes between patients with and without a cirrhotic liver undergoing laparoscopic liver resection: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2018 Aug 10. pii: S2210-7401(18)30120.
    PubMed     Abstract available

    May 2018
  16. DUMORTIER J, Maucort-Boulch D, Poinsot D, Thimonier E, et al
    Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease.
    Clin Res Hepatol Gastroenterol. 2018 May 31. pii: S2210-7401(18)30087.
    PubMed     Abstract available

  17. PINERO F, Costa P, Boteon YL, Duque SH, et al
    A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America.
    Clin Res Hepatol Gastroenterol. 2018 May 14. pii: S2210-7401(18)30074.
    PubMed     Abstract available

    March 2018
  18. BIHARI C, Patil A, Sarin SK
    Adequate platelet counts in cirrhosis for laboratory-based optimum platelet functions.
    Clin Res Hepatol Gastroenterol. 2018 Mar 31. pii: S2210-7401(18)30044.

  19. SUH SW, Choi YS, Hong SA, Kang H, et al
    Preoperative erythropoietin treatment improves survival following major hepatic resection in a cirrhotic rat model.
    Clin Res Hepatol Gastroenterol. 2018 Mar 23. pii: S2210-7401(17)30268.
    PubMed     Abstract available

  20. HUNG TH, Lee HF, Tseng CW, Tsai CC, et al
    Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding.
    Clin Res Hepatol Gastroenterol. 2018 Mar 15. pii: S2210-7401(17)30267.
    PubMed     Abstract available

  21. MALLET M, Weiss N, Thabut D, Rudler M, et al
    Why and when to measure ammonemia in cirrhosis?
    Clin Res Hepatol Gastroenterol. 2018 Mar 15. pii: S2210-7401(18)30031.
    PubMed     Abstract available

    February 2018
  22. BENHAMED F, Postic C
    A new pathway to eSCAPe lipotoxicity.
    Clin Res Hepatol Gastroenterol. 2018;42:3-5.
    PubMed     Abstract available

    December 2017
  23. PERNOT S, Velut G, Kourie RH, Amouyal G, et al
    5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases.
    Clin Res Hepatol Gastroenterol. 2017 Dec 7. pii: S2210-7401(17)30260.
    PubMed     Abstract available

  24. SANG W, Lv B, Li K, Lu Y, et al
    Therapeutic efficacy and safety of umbilical cord mesenchymal stem cell transplantation for liver cirrhosis in Chinese population: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Dec 6. pii: S2210-7401(17)30259.
    PubMed     Abstract available

    November 2017
  25. BRUSTIA R, Savier E, Scatton O
    Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Nov 18. pii: S2210-7401(17)30214.
    PubMed     Abstract available

    October 2017
  26. ZHANG CH, Zheng L, Gui L, Lin JY, et al
    Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.
    Clin Res Hepatol Gastroenterol. 2017 Oct 11. pii: S2210-7401(17)30187.
    PubMed     Abstract available

  27. LEMOINNE S, Marteau P
    Gut microbial profile in primary biliary cholangitis: Towards bioindicators.
    Clin Res Hepatol Gastroenterol. 2017;41:507-508.

    September 2017
  28. MURATORI P, Muratori L
    Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2017;41:e47.

    August 2017
  29. MA X, Sun D, Li C, Ying J, et al
    Statin use and virus-related cirrhosis: A systemic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Aug 30. pii: S2210-7401(17)30180.
    PubMed     Abstract available

    April 2017
  30. TRAN MINH M, Mazzola A, Perdigao F, Charlotte F, et al
    Primary hepatic angiosarcoma and liver transplantation: Radiological, surgical, histological findings and clinical outcome.
    Clin Res Hepatol Gastroenterol. 2017 Apr 14. pii: S2210-7401(17)30077.
    PubMed     Abstract available

  31. SAXENA P, Bihari C, Mirza R, Bhadoria AS, et al
    Exogenous growth factor based regenerative therapy in alcoholic cirrhosis patients renders limited effect on hemostatic elements.
    Clin Res Hepatol Gastroenterol. 2017 Apr 12. pii: S2210-7401(17)30080.

    March 2017
  32. JAMSHIDZADEH A, Heidari R, Latifpour Z, Ommati MM, et al
    Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic rats.
    Clin Res Hepatol Gastroenterol. 2017 Mar 7. pii: S2210-7401(17)30009.
    PubMed     Abstract available

  33. CHEN Y, Li L, Qian X, Ge Y, et al
    High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017;41:190-196.
    PubMed     Abstract available

  34. BAO S, Zheng J, Li N, Huang C, et al
    Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage.
    Clin Res Hepatol Gastroenterol. 2017;41:147-155.
    PubMed     Abstract available

  35. KANG HG, Wang BZ, Zhang J, Liu MR, et al
    Combination of temsirolimus and adriamycin exhibits an enhanced antitumor effect in hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017;41:197-203.
    PubMed     Abstract available

  36. HUANG R, Zhang Q, Huang Q, Zu M, et al
    Number and function of circulating endothelial progenitor cells in patients with primary Budd-Chiari syndrome.
    Clin Res Hepatol Gastroenterol. 2017;41:139-146.
    PubMed     Abstract available

  37. MA W, Wang H, Jing W, Zhou F, et al
    Downregulation of long non-coding RNAs JPX and XIST is associated with the prognosis of hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017;41:163-170.
    PubMed     Abstract available

    February 2017
  38. LI K, Liu H, Guo T
    Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients.
    Clin Res Hepatol Gastroenterol. 2017 Feb 3. pii: S2210-7401(17)30003.
    PubMed     Abstract available

  39. MOTAMED N, Rabiee B, Poustchi H, Dehestani B, et al
    Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
    Clin Res Hepatol Gastroenterol. 2017;41:31-38.
    PubMed     Abstract available

  40. SHIN JH, Jung JH
    Non-alcoholic fatty liver disease and flavonoids: Current perspectives.
    Clin Res Hepatol Gastroenterol. 2017;41:17-24.
    PubMed     Abstract available

  41. MANENTI A, Roncati L, Simonini E, Farinetti A, et al
    HCC chemoembolization: Still a challenge.
    Clin Res Hepatol Gastroenterol. 2017;41:e14-e16.

  42. TAS A, Kara B, Yilmaz C, Suat Yalcin M, et al
    Fulminant Budd-Chiari syndrome due to ecstasy.
    Clin Res Hepatol Gastroenterol. 2017;41:e12-e13.

  43. CHEN P, Yuan P, Chen B, Sun J, et al
    Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017;41:75-85.
    PubMed     Abstract available

  44. WATSON A, Bul V, Staudacher J, Carroll R, et al
    The predictors of mortality and secular changes in management strategies in emphysematous gastritis.
    Clin Res Hepatol Gastroenterol. 2017;41:e1-e7.
    PubMed     Abstract available

    December 2016
  45. ZHENG L, Qin J, Sun L, Gui L, et al
    Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension.
    Clin Res Hepatol Gastroenterol. 2016 Dec 30. pii: S2210-7401(16)30203.
    PubMed     Abstract available

    November 2016
  46. XU SL, Zhang YC, Wang GY, Yang Q, et al
    Survival analysis of sirolimus-based immunosuppression in liver transplantation in patients with hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2016 Nov 4. pii: S2210-7401(16)30046.
    PubMed     Abstract available

    July 2016
  47. TAS A, Olmez S, Yalcin MS
    A rare cause of elevated alpha fetoprotein in patient with cirrhosis.
    Clin Res Hepatol Gastroenterol. 2016 Jul 5. pii: S2210-7401(16)30084.

    May 2016
  48. WOSIEWICZ P, Zorniak M, Hartleb M, Baranski K, et al
    Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability.
    Clin Res Hepatol Gastroenterol. 2016 May 5. pii: S2210-7401(16)30048.
    PubMed     Abstract available

    April 2016
  49. LIU L, Zhang C, Hu Y, Zhou L, et al
    Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation.
    Clin Res Hepatol Gastroenterol. 2016 Apr 6. pii: S2210-7401(16)30038.
    PubMed     Abstract available

    February 2016
  50. ISMAIL H, Broniszczak D, Markiewicz-Kijewska M, Ciopinski M, et al
    Metastases of pancreatic neuroendocrine tumor to the liver as extremely rare indication for liver transplantation in children. Case report and review of the literature.
    Clin Res Hepatol Gastroenterol. 2016 Feb 2. pii: S2210-7401(15)00292.
    PubMed     Abstract available

    November 2015
  51. RASZEJA-WYSZOMIRSKA J, Wunsch E, Krawczyk M, Rigopoulou EI, et al
    Assessment of health related quality of life in polish patients with primary biliary cirrhosis.
    Clin Res Hepatol Gastroenterol. 2015 Nov 24. pii: S2210-7401(15)00260.
    PubMed     Abstract available

    October 2015
  52. GAO PJ, Gao J, Li Z, Hu ZP, et al
    Liver transplantation in adults with portal vein thrombosis: Data from the China Liver Transplant Registry.
    Clin Res Hepatol Gastroenterol. 2015 Oct 20. pii: S2210-7401(15)00121.
    PubMed     Abstract available

    September 2015
  53. HU Z, Qian Z, Wu J, Zhou J, et al
    Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-centre comparison of living donor and deceased donor transplantation.
    Clin Res Hepatol Gastroenterol. 2015 Sep 14. pii: S2210-7401(15)00208.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.